NGeneBio Co., Ltd. (KOSDAQ:354200)
1,698.00
-17.00 (-0.99%)
At close: Oct 2, 2025
NGeneBio Revenue
NGeneBio had revenue of 1.85B KRW in the quarter ending June 30, 2025, a decrease of -8.93%. This brings the company's revenue in the last twelve months to 6.63B, up 32.68% year-over-year. In the year 2024, NGeneBio had annual revenue of 5.69B with 30.80% growth.
Revenue (ttm)
6.63B
Revenue Growth
+32.68%
P/S Ratio
6.40
Revenue / Employee
n/a
Employees
n/a
Market Cap
42.39B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 5.69B | 1.34B | 30.80% |
Dec 31, 2023 | 4.35B | -6.67B | -60.51% |
Dec 31, 2022 | 11.02B | 3.85B | 53.81% |
Dec 31, 2021 | 7.16B | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full Definition